A paramilitary group, United Nigeria Chaplaincy, UNC,is seeking the cooperation of the media to ensure that its humanitarian services get to the public.
Speaking when members of the group paid courtesy visit to the Managing Director of Anambra Broadcasting Service, ABS, Sir Chido Obidiegwu, the group, led by the Anambra State Commandant, Mr David Arinzechukwu said UNC is functioning in different parts of the country where there is need for peace building.
Mr Arinzechukwu said though still self-funded and awaiting formal recognition by the federal government, the group needs government support in the area of funding, but maintained that lack of it will not deter them from carrying out humanitarian services, as their existence will diminish if they stop.
In Anambra, the group said they are in the peace building process in troubled communities, and can do more with necessary support of the government.
Contributing, the National Director for Logistics, Mr Eugene Okeke, said non-recognition of the group by the federal government and lack of funding are still challenges to members, adding that when recognized, UNC will continue to help in bringing peace where there is crisis .
Responding, the Managing Director of ABS, Sir Chido said the establishment has a responsibility of disseminating information that will help in building the society.
He noted that non-recognition of the group by the federal government negatively affects people who may wish to collaborate with them, and urged members of the group to sustain public relations campaign aimed at rebuilding the group’s image, promising the help of the ABS.
Joined in receiving the UNC delegation were the Acting Director of News and Current Affairs of the ABS, Mrs Juddy-Jeff Nwabueze, and the Director of Commercial Services, Mrs Beatrice Akwanamnye, while the UNC delegation included, National Director for Training, Mr James Obasi, Anambra State General Secretary, Mr Ben Odiwe, Deputy Operations, Anambra State Command, Mr Nnamdi Enechukwu, National Storekeeper, Mrs Esther Obiozor.
Comments are closed for this post.